Interviewing one of the Leading Biotech Investors in Scandinavia

05/04/2016 - 1 minute

The Karolinska Institute (Sweden) is worldwide famous for giving the Nobel Prize every year…

It’s also home of Karolinska Development, an investment company span out from Karolinska Institute. I had the chance to meet with Viktor Drvota, its Chief Investment Officer at BIO-Europe Spring 2016 in Stockholm.

We had a chance to talk about the history of Karolinska Development, how it evolved from being a pharma company to an investor quoted on the Nordic NASDAQ.

I also asked him questions about the latest investment in Aprea with an impressive €46M series A, the largest of the decade! Lastly, I asked him what he thinks of the Swedish Biotech ecosystem.

 

I’ll let you check the video for his answers…Please accept preferences cookies to watch this video.

Feature Image Credit: Philip Hemme interviewing Viktor Drvota at Bio-Spring in Stockholm

 

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT
Do you want to remove this advert? Become a member!
ADVERTISEMENT
Do you want to remove this advert? Become a member!